Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Leszek Tylicki's publication output changed over time?
ScholarIQpublication output · 2001–2021
Output grew0% over the shown period — from 1 works in 2001 to 1 in 2021.
1
1
1
1
1
1
1
2
1
1
2001200220032004200520062008201220162021
What are the most-cited papers on Leszek Tylicki?
ScholarIQmost cited works
Triple Pharmacological Blockade of the Renin-Angiotensin-Aldosterone System in Nondiabetic CKD: An Open-Label Crossover Randomized Controlled Trial
Leszek Tylicki, Przemysław Rutkowski, Marcin Renke, Wojciech Larczyński, Ewa Aleksandrowicz, Wiesława Łysiak−Szydłowska, Bolesław Rutkowski
American Journal of Kidney Diseases. 2008104 Citations
Antioxidants: A Possible Role in Kidney Protection
Leszek Tylicki, Boleslaw Rutkowski, Walter H. Hörl
Kidney & Blood Pressure Research. 200372 Citations
Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis
Przemysław Rutkowski, Leszek Tylicki, Marcin Renke, Grzegorz Korejwo, Zbigniew Zdrojewski, Boleslaw Rutkowski
American Journal of Kidney Diseases. 200456 Citations
Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions
Leszek Tylicki, Sławomir Lizakowski, Boleslaw Rutkowski
Journal of Nephrology. 201252 Citations
Nonsteroidal anti-inflammatory drug use in patients with chronic kidney disease
Zbigniew Heleniak, Magdalena Cieplińska, Tomasz Szychliński, Dymitr Rychter, Kalina Jagodzińska, Alicja Kłos, Izabela Kuźmiuk, Marzena Tylicka, Leszek Tylicki, Bolesław Rutkowski, Alicja Dębska‐Ślizień
Journal of Nephrology. 201651 CitationsOPEN ACCESS
Related on ScholarIQ
Gdańsk Medical University
Institution
Triple Pharmacological Blockade of the Renin-Angiotensin-Aldosterone System in Nondiabetic CKD: An Open-Label Crossover Randomized Controlled Trial
Paper
Antioxidants: A Possible Role in Kidney Protection
Paper
Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis
Paper
Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions
Paper
Nonsteroidal anti-inflammatory drug use in patients with chronic kidney disease
Paper